Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical Candidate
Evans, Catherine A., Liu, Tao, Lescarbeau, André, Nair, Somarajan J., Grenier, Louis, Pradeilles, Johan A., Glenadel, Quentin, Tibbitts, Thomas, Rowley, Ann M., DiNitto, Jonathan P., Brophy, Erin E.,Language:
english
Journal:
ACS Medicinal Chemistry Letters
DOI:
10.1021/acsmedchemlett.6b00238
Date:
August, 2016
File:
PDF, 511 KB
english, 2016